Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VIATRIS-INC-115117632/news/Biocon-Biologics-and-Viatris-Launch-Abevmy-bBevacizumab-Their-Third-Oncology-Biosimilar-in-Canad-40489055/?utm_source=whatsapp&utm_medium=social&utm_campaign=share